Biotech1 month ago
PharmaMar Grows Double-Digit on the Stock Market After Reporting Positive Results of a Trial
PharmaMar's shares surged 32.7% after announcing positive phase III trial results for Zepzelca, combined with Tecentriq, in treating advanced small cell lung cancer. This combination significantly...